Phil Bryan, vaccines safety lead for the UK’s Medicines and Healthcare Products Regulatory Agency, said, “More than 11 million doses of the AstraZeneca vaccine have now been administered across the UK. Reports of blood clots received so far are not greater than the number that would have occurred naturally in the vaccinated population.” He added that the agency was keeping the issue under close review but that available evidence did not confirm that the vaccine was the cause. Four weeks after receiving the initial dose, the Oxford jab appeared to reduce a person''''''''s risk of hospital admission by 94%. Those who received the Pfizer jab had a reduction in risk of 85% between 28 and 34 days after the first dose. 法国总统先说牛津疫苗quasi-effective, 苏格兰的数据出来，接种牛津疫苗四个星期后，入院率降低９４％，辉瑞降低８５％。 牛津和辉瑞同样有效，又改口。 牛津疫苗这次在欧洲的负面报导不知道和政治有没有关联，但一边不信任牛津，一边又指责阿斯利康供货不力，要求阿斯利康英国生产线上的疫苗转供欧洲，意大利又拦截一批要运往澳洲的牛津疫苗，you can''''''''t get your head around, 他们到底是要用还是不要用。 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/968414/COVID-19_AstraZeneca_Vaccine_Analysis_Print.pdf 这是英国疫苗接种截止二月底的数据，英国牛津疫苗接种超过1千一百万人了，和辉瑞基本是对半开，接种人群里blood clot 的数据也基本上是差不多的，也是从高危人群８０＋开始打的，数据良好，对UK Variant 效果也是不错的。 不管怎么说，欧洲民众不信任牛津疫苗的种子已经种下，反正也没人打了，要不他们就都送给买不到疫苗的愿意打牛津疫苗的别的国家吧，既不用冒险打牛津疫苗，又能帮助穷国，一举两得。
回复 3楼phlin的帖子 你在哪里看到的AZ致血栓百万分之六？我查了一下，正常情况下，血栓发病率，每千人中，80以上13人，60-69以上5人，现在还没有证据表明AZ疫苗额外导致血栓。当然，任何疫苗都有可能产生严重的副作用，那就需要药监局权衡发生的机率和打疫苗的好处了。 The incidence of venous thromboembolism in the >80 years age group was 13.16, in the 70-79 age group 7.76 and in the 60-69 age group 5.10 per 1000 person years. So for every 1 million people immunised in these age groups we would expect to see about 1097, 645 and 425 episodes of thromboembolism in the month after immunization anyway. Now we do not know whether there was any particular aspect of the thromboembolic events in the recent reports from Europe that would make those cases more unusual and so more concerning. With the information currently available it seems likely that these reported adverse events are not caused by the vaccine, but we will see what conclusions the appropriate authorities come to after reviewing all the evidence. https://www.sciencemediacentre.org/expert-reaction-to-reports-that-denmark-has-paused-vaccination-with-the-oxford-astrazeneca-vaccine-as-a-precaution-after-some-reports-of-blood-clots/
回复 3楼phlin的帖子 你在哪里看到的AZ致血栓百万分之六？我查了一下，正常情况下，血栓发病率，每千人中，80以上13人，60-69以上5人，现在还没有证据表明AZ疫苗额外导致血栓。当然，任何疫苗都有可能产生严重的副作用，那就需要药监局权衡发生的机率和打疫苗的好处了。 The incidence of venous thromboembolism in the >80 years age group was 13.16, in the 70-79 age group 7.76 and in the 60-69 age group 5.10 per 1000 person years. So for every 1 million people immunised in these age groups we would expect to see about 1097, 645 and 425 episodes of thromboembolism in the month after immunization anyway. Now we do not know whether there was any particular aspect of the thromboembolic events in the recent reports from Europe that would make those cases more unusual and so more concerning. With the information currently available it seems likely that these reported adverse events are not caused by the vaccine, but we will see what conclusions the appropriate authorities come to after reviewing all the evidence. https://www.sciencemediacentre.org/expert-reaction-to-reports-that-denmark-has-paused-vaccination-with-the-oxford-astrazeneca-vaccine-as-a-precaution-after-some-reports-of-blood-clots/ oceanseven 发表于 2021-03-14 09:40
系统提示：若遇到视频无法播放请点击下方链接
https://www.youtube.com/embed/-Dv6IGX2o2k
Four weeks after receiving the initial dose, the Oxford jab appeared to reduce a person''''''''s risk of hospital admission by 94%. Those who received the Pfizer jab had a reduction in risk of 85% between 28 and 34 days after the first dose.
法国总统先说牛津疫苗quasi-effective, 苏格兰的数据出来，接种牛津疫苗四个星期后，入院率降低９４％，辉瑞降低８５％。 牛津和辉瑞同样有效，又改口。
牛津疫苗这次在欧洲的负面报导不知道和政治有没有关联，但一边不信任牛津，一边又指责阿斯利康供货不力，要求阿斯利康英国生产线上的疫苗转供欧洲，意大利又拦截一批要运往澳洲的牛津疫苗，you can''''''''t get your head around, 他们到底是要用还是不要用。
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/968414/COVID-19_AstraZeneca_Vaccine_Analysis_Print.pdf
这是英国疫苗接种截止二月底的数据，英国牛津疫苗接种超过1千一百万人了，和辉瑞基本是对半开，接种人群里blood clot 的数据也基本上是差不多的，也是从高危人群８０＋开始打的，数据良好，对UK Variant 效果也是不错的。
不管怎么说，欧洲民众不信任牛津疫苗的种子已经种下，反正也没人打了，要不他们就都送给买不到疫苗的愿意打牛津疫苗的别的国家吧，既不用冒险打牛津疫苗，又能帮助穷国，一举两得。
AZ 疫苗 致血栓率百萬分之六
國 苗 致死率百萬分之四十
等 Pfizer
好象没有
德国这里 几百万 80 岁以上的 老头老太太们都打过了
目前没发现有任何问题
你在哪里看到的AZ致血栓百万分之六？我查了一下，正常情况下，血栓发病率，每千人中，80以上13人，60-69以上5人，现在还没有证据表明AZ疫苗额外导致血栓。当然，任何疫苗都有可能产生严重的副作用，那就需要药监局权衡发生的机率和打疫苗的好处了。
The incidence of venous thromboembolism in the >80 years age group was 13.16, in the 70-79 age group 7.76 and in the 60-69 age group 5.10 per 1000 person years. So for every 1 million people immunised in these age groups we would expect to see about 1097, 645 and 425 episodes of thromboembolism in the month after immunization anyway. Now we do not know whether there was any particular aspect of the thromboembolic events in the recent reports from Europe that would make those cases more unusual and so more concerning.
With the information currently available it seems likely that these reported adverse events are not caused by the vaccine, but we will see what conclusions the appropriate authorities come to after reviewing all the evidence.
https://www.sciencemediacentre.org/expert-reaction-to-reports-that-denmark-has-paused-vaccination-with-the-oxford-astrazeneca-vaccine-as-a-precaution-after-some-reports-of-blood-clots/
该内容需要3000魅力值以上才能阅览
中國時報啊
https://www.chinatimes.com/realtimenews/20210312005364-260509?chdtv
藥師林士峰表示，血栓發生率約萬分之0.06，AZ疫苗的保護力卻只有70~90%之間，台灣應該跟著停打AZ疫苗，會是比較有利的選項。
一年一萬帖 一天三十帖
很難嗎?
刁 叫你們要好好鬥爭
你們一天帖不到三十帖
對得起領的那一百塊人民幣嗎
该内容需要6000魅力值以上才能阅览
呆蛙人气质好，新冠都不会感染。。还怕什么疫苗。欧洲人气质没有呆蛙好。。呆蛙放心打就对了
不如 Pfizer